Combined Exercise and Nutrition Intervention for Sarcopenia in Patients With Hip Fracture: CENTERS; A Multicenter Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to demonstrate the effect of combined exercise-nutrition intervention in old adults with sarcopenia. This study will be conducted with prospectively randomized controlled trial comparing outcome of combined exercise-nutrition intervention with conventional medical care. Handgrip strength, gait speed, knee extensor muscle power, physical performance, muscle mass using DEXA, quality of life, activities of daily living, sarcopenia screening questionnaire, nutritional assessment will be evaluated on baseline, 12-weeks and 24-weeks after intervention

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Maximum Age: 90
Healthy Volunteers: f
View:

• patients older than 65 years and under 90 years

• patients who meet the criteria for the Asian Working Group for Sarcopenia (AWGS) 2019

• patients who had metabolic syndrome

Locations
Other Locations
Republic of Korea
Seoul Bumin Hospital
RECRUITING
Seoul
Contact Information
Primary
Yongchan Ha, phD
hayongch@naver.com
01085218328
Backup
Eunsuk Kim, bachelor
unanhi@bumin.co.kr
01089353081
Time Frame
Start Date: 2022-03-29
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 118
Treatments
Experimental: Combined exercise nutrition intervention group
Customized exercise and nutrition intervention(food for nutrition:whey protein isolate powder) by underlying disease and functional state for 12 weeks during intervention period.~\*Whey protein isolate powder is provided to compensate for the insufficient amount of protein calculated through a questionnaire.
Active_comparator: Conventional medial care group
Conventional medical care service for 12weeks during intervention period.
Related Therapeutic Areas
Sponsors
Leads: Seoul Bumin Hospital
Collaborators: National Evidence-Based Healthcare Collaborating Agency

This content was sourced from clinicaltrials.gov